Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000884272 | SCV001027639 | benign | Neu-Laxova syndrome 2 | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004712929 | SCV005266955 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004541791 | SCV004777789 | likely benign | PSAT1-related disorder | 2020-06-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |